CHF Solutions, Inc. to Present at the MicroCap Rodeo Investor Conference on October 15, 2019
October 08 2019 - 8:00AM
CHF Solutions, Inc. (Nasdaq: CHFS) today announced that John Erb,
the company’s chairman and CEO, will be presenting and meeting with
investors at the first annual MicroCap Rodeo investor conference on
October 15, 2019 at 8:35 AM CT in meeting room 416 B. The
conference will be held October 15-16 at the Hilton Austin -
Downtown in Austin, Texas.
For those interested in attending the conference or arranging a
one-on-one meeting with management, please contact conference
organizers at microcaprodeo.com.
About CHF SolutionsCHF Solutions, Inc. (Nasdaq:
CHFS) is a medical device company dedicated to changing the lives
of patients suffering from fluid overload through science,
collaboration, and innovative technology. The company is focused on
developing, manufacturing, and commercializing the Aquadex FlexFlow
system for ultrafiltration therapy. CHF Solutions is a Delaware
corporation headquartered in Minneapolis, Minnesota with wholly
owned subsidiaries in Australia and Ireland. The company has been
listed on the Nasdaq Capital Market since February 2012.
Forward-Looking StatementsCertain statements in
this release are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, including
without limitation, statements regarding the company’s
participation in investor failure conferences.
Forward-looking statements are predictions, projections and other
statements about future events that are based on current
expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many factors could cause actual future events to
differ materially from the forward-looking statements in this
release, including, without limitation, those risk associated with
our ability to execute on our commercialization strategy, the
possibility that we may be unable to raise sufficient funds
necessary for our anticipated operations, our post-market clinical
data collection activities, benefits of our products to patients,
our expectations with and physician acceptance of our products,
potentially competitive product offerings, intellectual property
protection, our ability to integrate acquired businesses, our
expectations regarding anticipated synergies with and benefits from
acquired businesses, and other risks and uncertainties described in
our filings with the SEC. Forward-looking statements speak
only as of the date when made. CHF Solutions does not
assume any obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
CONTACTS:
INVESTORS: Claudia Napal Drayton Chief
Financial Officer CHF Solutions, Inc. 952-345-4205
ir@chf-solutions.com
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Mar 2024 to Apr 2024
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Apr 2023 to Apr 2024